Zobrazeno 1 - 10 of 17 pro vyhledávání: '"E. I. Minder"'
1
Akademický článek
Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL
Autor: G. Biolcatti, S. Hanneken, E. I. Minder, N. J. Neumann, J. H. P. Wilson, P. J. Wolgen, D. J. Wright, A. J. Lloyd
Publikováno v: Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-8 (2021)
Abstract Background A novel treatment has been developed for erythropoietic protoporphyria (EPP) (a rare condition that leaves patients highly sensitive to light). To fully understand the burden of EPP and the benefit of treatment, a novel patient re
Externí odkaz: https://doaj.org/article/2c9d15ce8ed5409c8a84cc284a18d928
Zobrazit plný text záznamu
3
Correction to: Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL
Autor: E. I. Minder, A. J. Lloyd, G. Biolcati, D. J. Wright, P. J. Wolgen, J. H. P. Wilson, Norbert J. Neumann, S. Hanneken
Publikováno v: Journal of Patient-Reported Outcomes
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-1 (2021)
A novel treatment has been developed for erythropoietic protoporphyria (EPP) (a rare condition that leaves patients highly sensitive to light). To fully understand the burden of EPP and the benefit of treatment, a novel patient reported outcome (PRO)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b843ddf11c914a913cc0962465405fba
https://doi.org/10.1186/s41687-021-00348-4
Zobrazit plný text záznamu
4
Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL
Autor: Norbert J. Neumann, S. Hanneken, A. J. Lloyd, P. J. Wolgen, G. Biolcati, D. J. Wright, J. H. P. Wilson, E. I. Minder
Publikováno v: Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-8 (2021)
Journal of Patient-Reported Outcomes
Journal of Patient-Reported Outcomes, 5(1):65. Springer International Publishing AG
Background A novel treatment has been developed for erythropoietic protoporphyria (EPP) (a rare condition that leaves patients highly sensitive to light). To fully understand the burden of EPP and the benefit of treatment, a novel patient reported ou
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a00b73a7c53b7450e7a449038ce9c6f2
https://doi.org/10.1186/s41687-021-00345-7
Zobrazit plný text záznamu
5
Elevation of troponin I in sepsis and septic shock
Autor: O Bertel, C Günter, E I Minder, Peter Ammann, T Fehr
Publikováno v: Intensive Care Medicine. 27:965-969
Objective: To detect myocardial damage in severe systemic inflammation by cTnI measurements in patients without acute coronary syndromes. Design: Prospective case control study. Setting: Tertiary referral center. Participants: Twenty patients with se
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b01b7ff133e8c620965f8345b725bd46
https://doi.org/10.1007/s001340100920
Zobrazit plný text záznamu
6
Prototype Application of a Robot in the Clinical Laboratory Enabling Fully Automated Quantification of Fecal Porphyrins
Autor: E. I. Minder, J. P. Vuilleumier, D J Vonderschmitt
Publikováno v: Clinical Chemistry. 38:516-521
Unpleasant specimens, sensitive analytes, and a lengthy chromatographic procedure were the main reasons we implemented fecal porphyrin analysis with a laboratory robot. We describe the system in detail and compare it with the same technique performed
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::09a5b8da4ee51b53694ce4b6d85e58ab
https://doi.org/10.1093/clinchem/38.4.516
Zobrazit plný text záznamu
7
Identification of a recurrent mutation in the protoporphyrinogen oxidase gene in Swiss patients with variegate porphyria: clinical and genetic implications
Autor: A M, Van Tuyll Van Serooskerke, X, Schneider-Yin, R J, Schimmel, R S, Bladergroen, P, Poblete-Gutiérrez, J, Barman, M, van Geel, J, Frank, E I, Minder
Publikováno v: Cellular and molecular biology (Noisy-le-Grand, France). 55(2)
Variegate porphyria (VP), one of the acute hepatic porphyrias, results from an autosomal dominantly inherited deficiency of protoporphyrinogen oxidase (PPOX), the seventh enzyme in heme biosynthesis. Affected individuals can develop both cutaneous sy
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::445a6b82f3a8f493471883b9156bcba8
https://pubmed.ncbi.nlm.nih.gov/19656457
Zobrazit plný text záznamu
8
Variations in the length of poly-C and poly-T tracts in intron 3 of the human ferrochelatase gene
Autor: J, Barman, X, Schneider-Yin, R, Mamet, N, Schoenfeld, E I, Minder
Publikováno v: Cellular and molecular biology (Noisy-le-Grand, France). 55(2)
The third intron of human ferrochelatase (FECH) gene contains according to NCBI, a poly-C (11) and a poly-T (24) tracts which are located approximately 900 bp upstream from the known splice modulating SNP IVS3-48 c/t. Ferrochelatase catalyses the las
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3ad00e410ce0204f350be4bbce394619
https://pubmed.ncbi.nlm.nih.gov/19656458
Zobrazit plný text záznamu
9
A systematic review of treatment options for dermal photosensitivity in erythropoietic protoporphyria
Autor: E I, Minder, X, Schneider-Yin, J, Steurer, L M, Bachmann
Publikováno v: Cellular and molecular biology (Noisy-le-Grand, France). 55(1)
Erythropoietic protoporphyria (EPP) is a rare inherited disease characterized by dermal photosensitivity due to the accumulation of photosensitizer protoporphyrin IX. We performed a systematic database search on studies related to treatment of EPP. A
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c4f58aa617a27d647a786517ee15f832
https://pubmed.ncbi.nlm.nih.gov/19268006
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje